Cost of managing severe cutaneous adverse drug reactions to first-line tuberculosis therapy in South Africa
{{output}}
Objective: To compare the cost of managing treatment-limiting cutaneous adverse drug reactions (CADRs) to first-line anti-tuberculosis drugs to an alternative strategy of immediate treatment initiation using second-line drugs in ... ...
